Danna nan don nuna banners ɗin ku akan wannan shafin kuma ku biya kawai don nasara

Labaran Waya

Sabuwar Gwajin Ganowar Jini don Ciwon Bipolar

Written by edita

ALCEDIAG ta sanar da ƙaddamar da EDIT-B Consortium, wanda Cibiyar Ƙirƙirar Ƙirƙira da Fasaha ta Turai don Lafiya (EIT Health). Wannan sabuwar haɗin gwiwar jama'a da masu zaman kansu na Turai da nufin haɓaka madaidaicin ilimin tabin hankali ta hanyar gabatar da ilimin halitta cikin aikin yau da kullun na asibiti. 

Kusan mutane miliyan 300 a duniya suna fama da bakin ciki. Bincike ya nuna cewa kusan kashi 40 cikin 7.5 na su na iya zama kuskuren ganewa kuma suna iya kamuwa da cutar bipolar. A sakamakon haka, ana jinkirin ganewar asali sau da yawa da matsakaita na shekaru XNUMX, yana kara tabarbare yanayin tunanin marasa lafiya da na jiki da kuma yanayin rayuwar 'yan uwansu.

Ƙungiyar EDIT-B tana da nufin magance wannan ƙalubalen bincike ta hanyar amfani da takamaiman RNA masu gyara halittu masu rai da hankali na wucin gadi don ingantawa da kasuwanci ingantaccen, abin dogaro, da gwajin jini mai sauri don gano cutar ta biyu.

Ƙungiyar ta haɗu da manyan mambobi daga ko'ina cikin Turai waɗanda za su yi aiki a cikin shekaru uku masu zuwa don cimma wannan burin: Alcediag, Alcen, Babban Birnin Denmark, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences , Asibitin Clínic de Barcelona, ​​Parc Sanitari Sant Joan de Déu, ProductLife Group da Synlab. Tare da jimlar kasafin kuɗi na Yuro miliyan 5.2, EDIT-B tana samun haɗin gwiwa daga Lafiyar EIT (€ 2.5M) da abokan haɗin gwiwa.

“Wannan aikin zai raba daidai gwargwado da rashin lafiyar unipolar. Wannan bambanci yana da mahimmanci a asibiti, saboda jiyya sun bambanta. EDIT-B Consortium ta tattara duk ƙwarewar da ta dace kuma a matsayin babban mai bincike a cikin gwaji na asibiti, ina fatan za mu iya tabbatar da gwajin da zai inganta rayuwar mutane da yawa da ke fama da cutar bipolar", in ji Farfesa Eduard Vieta daga Asibiti. Clínic de Barcelona.

SYNLAB shine mai ba da sabis na bincike na farko a Turai, wanda yake a cikin ƙasashe 36 a cikin nahiyoyi 4 kuma ya himmantu don haɓaka mafita mai ƙima ga marasa lafiya waɗanda ke mai da hankali kan ƙimar kiwon lafiya da ƙimar abokin ciniki.

Maurizio Ferrari, SYNLAB Babban Jami'in Kula da Lafiya na Italiya ya ce: "Kirkirar lafiya a cikin kiwon lafiya muhimmin ginshiƙi ne ga abokan ciniki kuma muna alfahari da kasancewa cikin wannan aikin binciken Turai wanda da gaske na iya taimaka wa marasa lafiya masu fama da tabin hankali."

"Ina alfaharin ganin cewa ƙungiyar EDIT-B karkashin jagorancin abokin aikinmu Alcediag - reshen Alcen - za ta magance ƙalubalen inganta ganewar cutar ta bipolar. A yin haka, suna tallafawa babban manufar Kiwon Lafiya ta EIT wanda shine taimaka wa 'yan ƙasa su rayu cikin koshin lafiya da tsawon rai sannan kuma a lokaci guda sanya haske kan lafiyar kwakwalwa wanda shine mabuɗin don kula da ingantaccen kulawa da walwalar al'ummominmu, "in ji Jean Marc Bourez. , Shugaban riko na EIT Health.

"A wannan Ranar Bipolar ta Duniya, ƙungiyar Alcediag ta yi farin cikin sanar da gudummawar da ta bayar don magance matsalar gano cutar bipolar. Muna alfahari da godiya ga abokan aikinmu da Lafiyar EIT don wannan damar don ciyar da kimiyya gaba tare da samun tasiri mai kyau kan rayuwar mutane, "in ji Alexandra Prieux, Shugaba na Alcediag.

Shafin Farko

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Leave a Comment

Share zuwa...